Boston Cambridge Biotech Networks Featured News

Boston Cambridge Biotech Networks News

• 

  Alzheimer’s Association Statement on Lecanemab Phase 3 Full Results

  November 30, 2022 Comments Off on Alzheimer’s Association Statement on Lecanemab Phase 3 Full Results

• 

  Biogen’s new Alzheimer’s drug slows cognitive decline: study

  November 30, 2022 Comments Off on Biogen’s new Alzheimer’s drug slows cognitive decline: study

• 

  Eisai’s expanded Alzheimer’s data leave open questions about safety and clinical benefit

  November 30, 2022 Comments Off on Eisai’s expanded Alzheimer’s data leave open questions about safety and clinical benefit

• 

  EISAI PRESENTS FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER’S DISEASE AT CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD) CONFERENCE

  November 30, 2022 Comments Off on EISAI PRESENTS FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER’S DISEASE AT CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD) CONFERENCE

• 

  ELEVEN EXPERTS FROM LEADING MEDICAL INSTITUTIONS AND EIGHT EXPERTS FROM EISAI* PUBLISH FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER’S DISEASE IN THE NEW ENGLAND JOURNAL OF MEDICINE

  November 30, 2022 Comments Off on ELEVEN EXPERTS FROM LEADING MEDICAL INSTITUTIONS AND EIGHT EXPERTS FROM EISAI* PUBLISH FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER’S DISEASE IN THE NEW ENGLAND JOURNAL OF MEDICINE

• 

  STAT+: Detailed data on Alzheimer’s therapy from Eisai, Biogen hold up to scientific scrutiny

  November 30, 2022 Comments Off on STAT+: Detailed data on Alzheimer’s therapy from Eisai, Biogen hold up to scientific scrutiny

• 

  Debating the role of Epstein-Barr virus in multiple sclerosis

  November 29, 2022 Comments Off on Debating the role of Epstein-Barr virus in multiple sclerosis

• 

  Emergency docs discuss takeaways from climate summit

  November 29, 2022 Comments Off on Emergency docs discuss takeaways from climate summit

• 

  Launch of the Merkin Prize in Biomedical Technology

  November 29, 2022 Comments Off on Launch of the Merkin Prize in Biomedical Technology

• 

  Legislative Update – Week of November 28, 2022

  November 29, 2022 Comments Off on Legislative Update – Week of November 28, 2022